The average BioMeter value in the third quarter of 2014 was $43.7 million, an increase from the $30.4 million value in the same quarter in 2013, and a slight increase from the blockbusterexcluding ...
In late 2012, Morrison & Foerster launched the BioMeter™, a quarterly index that measures the health of the biotechnology industry. The BioMeter averages up-front payments in licensing, collaboration, ...
The MoFo BioMeter for the first quarter of 2014 shows a decrease in average BioMeter value in a quarter dominated by early stage deals. Total dealmaking activity showed an uptick compared to the same ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback